"Researchers are making progress toward understanding how some cases of glaucoma begin. A new study from the National Eye Institute reveals that myocilin—a protein linked to a significant fraction of glaucoma—is needed to insulate peri"...
VIGAMOX® solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
Streptococcus viridans group
Haemophilus parainfluenzae *
*Efficacy for this organism was studied in fewer than 10 infections.
Dosage Forms and Strengths
4 mL bottle filled with 3 mL sterile ophthalmic solution of moxifloxacin hydrochloride, 0.5% as base.
VIGAMOX® solution is supplied as a sterile ophthalmic solution in Alcon's DROP-TAINER® dispensing system consisting of a natural low density polyethylene bottle and dispensing plug and tan polypropylene closure. Tamper evidence is provided with a shrink band around the closure and neck area of the package.
3 mL in a 4 mL bottle - NDC 0065-4013-03
Storage: Store at 2°C- 25°C (36°F - 77°F).
Manufactured by Alcon Laboratories, Inc. Fort Worth, TX 76134 USA. Licensed to Alcon, Inc. by Bayer Schering Pharma AG.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/24/2011
Additional Vigamox Information
Vigamox - User Reviews
Vigamox User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.